SE436570B - Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan - Google Patents

Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan

Info

Publication number
SE436570B
SE436570B SE7702272A SE7702272A SE436570B SE 436570 B SE436570 B SE 436570B SE 7702272 A SE7702272 A SE 7702272A SE 7702272 A SE7702272 A SE 7702272A SE 436570 B SE436570 B SE 436570B
Authority
SE
Sweden
Prior art keywords
benzotiazol
pyrimido
carboxamides
tetrazolyl
oxo
Prior art date
Application number
SE7702272A
Other languages
English (en)
Swedish (sv)
Other versions
SE7702272L (sv
Inventor
J S Bindra
S B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7702272L publication Critical patent/SE7702272L/xx
Publication of SE436570B publication Critical patent/SE436570B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
SE7702272A 1976-03-29 1977-03-01 Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan SE436570B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/671,030 US4041163A (en) 1976-03-29 1976-03-29 N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents

Publications (2)

Publication Number Publication Date
SE7702272L SE7702272L (sv) 1977-09-30
SE436570B true SE436570B (sv) 1985-01-07

Family

ID=24692862

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702272A SE436570B (sv) 1976-03-29 1977-03-01 Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan

Country Status (32)

Country Link
US (1) US4041163A (pt)
JP (1) JPS52118497A (pt)
AR (1) AR215886A1 (pt)
AT (1) AT355030B (pt)
BE (1) BE852485A (pt)
BG (1) BG27757A3 (pt)
CA (1) CA1079276A (pt)
CH (1) CH606019A5 (pt)
CS (1) CS198236B2 (pt)
DD (1) DD130247A5 (pt)
DE (1) DE2712079C3 (pt)
DK (1) DK146160C (pt)
ES (1) ES456944A1 (pt)
FI (1) FI60871C (pt)
FR (1) FR2346357A1 (pt)
GB (2) GB1560923A (pt)
GR (1) GR72695B (pt)
HU (1) HU173643B (pt)
IE (1) IE44031B1 (pt)
IL (1) IL51616A (pt)
LU (1) LU76970A1 (pt)
NL (1) NL166945C (pt)
NO (1) NO150044C (pt)
NZ (1) NZ183634A (pt)
PH (1) PH12757A (pt)
PL (1) PL103466B1 (pt)
PT (1) PT66321B (pt)
RO (1) RO71888A (pt)
SE (1) SE436570B (pt)
SU (1) SU784782A3 (pt)
YU (1) YU40669B (pt)
ZA (1) ZA771485B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4230707A (en) * 1979-08-27 1980-10-28 Warner-Lambert Company Oxo-pyrido[1,2-a]thienopyrimidine compounds and methods for their production
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4414388A (en) * 1979-11-23 1983-11-08 Pfizer Inc. 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
DK151811C (da) * 1979-11-23 1988-06-06 Pfizer Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
US4423048A (en) * 1979-11-23 1983-12-27 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4535081A (en) * 1979-11-23 1985-08-13 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
JPS59163735U (ja) * 1983-04-14 1984-11-02 モリタ工業株式会社 家庭用風呂釜の給排気管装置
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
US4762840A (en) * 1984-02-13 1988-08-09 Roussel Uclaf Pyrimido[2,1-b]benzothiazoles having antiallergic activity
US4879295A (en) * 1986-09-27 1989-11-07 Sawai Pharmaceutical Co., Ltd. N-tetrazolyl thiazolecarboxyamide derivatives and their use
US5063228A (en) * 1990-05-31 1991-11-05 A. H. Robbins Company, Incorporated 4-(substitutedaminoethyl)-3,4-dihydro-2-alkylpyrimido[1,6-a]benzimidazol-1(2H)-ones as antiarrhythmic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491944A (de) * 1966-11-29 1970-06-15 Ciba Geigy Verfahren zur Herstellung von benzheterocyclischen Verbindungen

Also Published As

Publication number Publication date
FR2346357A1 (fr) 1977-10-28
ATA183877A (de) 1979-07-15
SU784782A3 (ru) 1980-11-30
PH12757A (en) 1979-08-09
US4041163A (en) 1977-08-09
FI60871B (fi) 1981-12-31
RO71888A (ro) 1982-09-09
NL166945B (nl) 1981-05-15
GR72695B (pt) 1983-12-01
FI770848A (pt) 1977-09-30
YU68277A (en) 1982-06-30
NL166945C (nl) 1981-10-15
PT66321B (en) 1978-08-14
FR2346357B1 (pt) 1980-09-19
AU2322277A (en) 1978-04-20
IL51616A0 (en) 1977-05-31
ZA771485B (en) 1978-12-27
IL51616A (en) 1980-06-30
NZ183634A (en) 1979-03-16
NO150044C (no) 1984-08-22
DD130247A5 (de) 1978-03-15
DE2712079C3 (de) 1981-07-09
BG27757A3 (en) 1979-12-12
CA1079276A (en) 1980-06-10
CS198236B2 (en) 1980-05-30
IE44031B1 (en) 1981-07-29
YU40669B (en) 1986-04-30
DK146160B (da) 1983-07-11
GB1560923A (en) 1980-02-13
JPS52118497A (en) 1977-10-04
NO150044B (no) 1984-04-30
PL103466B1 (pl) 1979-06-30
DE2712079B2 (de) 1980-08-14
BE852485A (fr) 1977-09-15
LU76970A1 (pt) 1977-07-22
FI60871C (fi) 1982-04-13
IE44031L (en) 1977-09-29
DE2712079A1 (de) 1977-10-06
NL7702895A (nl) 1977-10-03
NO770782L (no) 1977-09-30
ES456944A1 (es) 1978-01-16
DK146160C (da) 1983-12-05
PT66321A (en) 1977-04-01
SE7702272L (sv) 1977-09-30
DK118277A (da) 1977-09-30
HU173643B (hu) 1979-07-28
AT355030B (de) 1980-02-11
GB1516964A (en) 1978-07-05
CH606019A5 (pt) 1978-10-13
JPS556639B2 (pt) 1980-02-18
AR215886A1 (es) 1979-11-15

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE436570B (sv) Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE431653B (sv) Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
FI773738A (fi) Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE430413B (sv) 1,4-difenyl-3-pyrazolin-5-oner med herbicid verkan
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE437026B (sv) Forfarande for framstellning av bensopyranderivat med antiallergisk verkan
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
SE425243B (sv) Forfarande for framstellning av n-(1'-alkyl-2'-pyrrolidylmetyl)-2,3-dimetoxi-5-sulfamoylbensamid med terapeutisk verkan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7702272-1

Effective date: 19880126

Format of ref document f/p: F